Topic

drug prices

19 petitions

Update posted 2 weeks ago

Petition to Janet Cruz, Florida State Senate, Florida State House, Florida Governor, Nicholas X. Duran, Janet Cruz

Put a price cap on insulin in Florida

I am a Type 1 diabetic and I have been since 1994. Just a couple of years ago the cost for a 3-month supply of Novolog insulin, which I have to inject every time I eat, was $100. Now, a 1-month supply costs $458.77 and there is no discount for a 3-month supply, meaning I would have to pay almost $1,500 for a 3-month supply -- about $6,000 a year for just one type of insulin. However, pricing elsewhere shows that this high cost is not necessary. Canada’s price for insulin is $90, and Colorado recently passed an insulin price cap of $100 per month. It's time for Florida to join Colorado in passing a price cap on this life-saving drug. Type 1 diabetes, which according to the CDC accounts for about 5 percent of all diagnosed cases of diabetes, is an autoimmune condition in which the body attacks and destroys the insulin-producing beta cells of the pancreas. Because their bodies cannot make insulin, type 1 diabetics require insulin prescriptions to live (in some extreme cases this is true for type 2 patients as well).  "When type 1 diabetics take less insulin than they need, at the expense of having higher blood sugars… glucose rises significantly and in an attempt to find alternate fuels for the brain, keto acids are formed which are potentially toxic and lower the body's pH. DKA (Diabetic Ketoacidosis), when left untreated, can be lethal, and can set in quickly. In the absence of insulin a person might get DKA within 24 hours," - Robert A. Gabbay, the Chief Medical Officer and Senior Vice President at Joslin Diabetes Center in Boston. The price of insulin has skyrocketed in recent years, with the three manufacturers — Sanofi, Novo Nordisk and Eli Lilly — raising the list prices of their products in near lock step, prompting outcry from patient groups and doctors who have pointed out that the rising prices appear to have little to do with increased production costs. In the United States, just three pharmaceutical giants hold patents that allow them to manufacture insulin: Eli Lilly, Sanofi and Novo Nordisk. Put together, the “big three” made more than $12 billion in profits in 2014, with insulin accounting for a large portion. Because of the incredibly high cost of insulin and other expensive supplies to handle their diabetes, many diabetics are forced into dire situations. Many diabetics have resorted to rationing insulin, risking their lives every day because they can’t afford to pay for their next vial. People are forced to choose between the insulin they need to survive, and keeping a roof over their head and food on the table for their families. People’s lives shouldn’t be put at risk because the insulin they require to live isn’t deemed “necessary” by insurance. The insulin price cap in Colorado has shown that it’s possible for states to take control of outrageous insulin pricing and as a result, to save lives. It’s time for Florida to join them in protecting Floridians with diabetes from avoidable health risks. I urge you to look into the legislation that Colorado passed as a potential example for Florida to follow.

Matthew Barnes
96,623 supporters
Update posted 1 month ago

Petition to Blue Cross Blue Shield

Blue Cross Blue Shield: Stop overcharging for insulin

You’ve probably heard some of their stories. People are dying because they can’t afford insulin. Thousands more are risking serious harm by skipping doses.  Incredibly, many of these people have health insurance.  How can that be? One big reason: Most insurance companies overcharge their members for insulin and other prescription drugs. I used to work for one of those companies—Blue Shield of California. Here’s how the companies overcharge. When insurers agree to cover specific brand name drugs, including insulin, they negotiate rebates to the insurer from the pharmaceutical companies. For insulin, the rebates average 70%. But when insurers calculate your cost-sharing payments, most base it off the full list price, not the after-rebate price they pay. So if the list price for a particular brand of insulin is $400 a month and the after-rebate cost to your insurer is $120, they’ll charge you $400. If you’ve met your deductible and your co-insurance is 20%, they’ll charge you $80 instead of $24. This practice is so clearly immoral that two of the biggest insurance companies, Aetna and UnitedHealthcare, have voluntarily stopped doing it. They now base member cost-sharing for insulin and other drugs on the discounted cost to the insurer, not the list price. But Blue Cross Blue Shield insurers (except for BCBS of North Carolina) continue to overcharge. The only reason they get away with it is that so few people know about it. With some public exposure and pressure, we can get them to do the right thing too. To end the insulin affordability crisis, we have to change how pharmaceutical companies and insurers behave.  Blue Cross Blue Shield: Stop overcharging for insulin and other drugs, and instead base member cost-sharing on the actual costs of drugs.

Michael Johnson
88,635 supporters
Update posted 2 months ago

Petition to Pennsylvania State House, Pennsylvania State Senate, Pennsylvania Governor

Price cap on insulin in Pennsylvania

In Pennsylvania, insulin costs $270 a vial - a prohibitively expensive price for many diabetics. This vial lasts a month at most for many diabetics. Others require three or more vials per month, skyrocketing the price up to $1000 a month for something they need to survive. However, pricing elsewhere shows that this high cost is not necessary. Canada’s price for insulin is $90, and Colorado recently passed an insulin price cap of $100 per month. It's time for Pennsylvania to join Colorado in passing a price cap on this life-saving drug. Sign and share this petition today to ask Pennsylvania state legislators to take a stand for those with diabetes by instituting an insulin price cap. Because of the incredibly high cost of insulin and other expensive supplies to handle their diabetes, many diabetics are forced into dire situations. Many diabetics have resorted to rationing insulin, risking their lives every day because they can’t afford to pay for their next vial. People are forced to choose between the insulin they need to survive, and keeping a roof over their head and food on the table for their families. I know firsthand how stressful paying for insulin can be. My girlfriend has Type 1 diabetes, and worries constantly about whether her insurance will continue to cover the costs of her insulin and related supplies. People’s lives shouldn’t be put at risk because the insulin they require to live isn’t deemed “necessary” by insurance. The insulin price cap in Colorado has shown that it’s possible for states to take control of outrageous insulin pricing and as a result, to save lives. It’s time for Pennsylvania to join them in protecting Pennsylvanians with diabetes from avoidable health risks. Please sign this petition to urge Pennsylvania state legislators to save lives with an insulin price cap.

Christian Luciano
84,435 supporters
Update posted 3 months ago

Petition to Google, Microsoft, Sundar Pichai, Satya Nadella, Bing

Google & Bing: STOP BLOCKING LOW DRUG PRICES! Don't let Big Pharma control search results.

A lawsuit alleges that Google and Microsoft's Bing have let Big Pharma front groups strategically suppress and manipulate search results, limiting Americans' access to information about more affordable drugs and lower cost pharmacies, such as those located in Canada. People deserve unbiased, unfiltered access to safe, affordable medication. Tell Google and Bing not to let Big Pharma dictate your search results for drug prices and safe online pharmacies. Take your wallet and health out of the hands of Big Pharma. Together, we can #stopbigpharma. Find out more: Stop Big Pharma Things have gotten worse in recent weeks: The top search results for “online pharmacies” on Google had been a listing of safe online pharmacies selling brand name medications at prices often 80-90% lower than those in the United States. Now, these results are buried pages down, virtually out of sight since March 12th. These medications are far more affordable because they are sold at licensed pharmacies in Canada and other countries where drug prices are lower. These safe online pharmacies have been independently verified by experts at a reputable U.S. website, PharmacyChecker.com.  On July 20, 2019, Microsoft’s Bing started placing pop-up warnings over search results for PharmacyChecker.com. Why? Because, as alleged in the lawsuit, groups funded by the pharmaceutical industry told them to. There is nothing dangerous about information from PharmacyChecker – unless you’re a drug company wanting to keep Americans paying the highest drug prices in the world. To end these anti-competitive practices, PharmacyChecker.com has filed a lawsuit charging a conspiracy among several groups allied with Big Pharma, and the company is requesting a preliminary injunction to bring immediate relief. But this conspiracy doesn’t have to stop you from accessing pharmacy and price information from PharmacyChecker.com. And it can’t stop you from signing a petition telling Google and Bing not to let Big Pharma dictate the drug prices and pharmacies you get to see!  To: Google CEO Pichai Sundararajan and Microsoft CEO Satya Nadella As alleged in a recent lawsuit, your companies have let groups funded by Big Pharma strategically suppress and manipulate search results in Google and Bing, limiting consumer access to information about more affordable drugs and lower cost pharmacies, such as those from Canada. This needs to stop. Google and Bing have specifically begun to suppress information from PharmacyChecker.com, a lawful U.S. company that helps Americans find safe and affordable medication from licensed pharmacies. Its webpages previously ranked highly in your search engines because of its trustworthiness. But you have been fed misinformation by programs funded by pharmaceutical companies that don’t approve of PharmacyChecker because it accredits licensed pharmacies outside the U.S.  You can stop this censorship now. Your actions are driving consumers into the hands of Big Pharma or rogue pharmacy sites, preventing Americans from safely finding affordable medication.

PharmacyChecker.com
4,609 supporters